Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frits van Rhee

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
The New England Journal of Medicine|August 24, 2022
Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal MassFrits van Rhee
Nature Clinical Practice. Oncology|November 7, 2007
Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?Frits van Rhee
Lancet (London, England)|May 18, 2010
Light-chain MGUS: implications for clinical practiceFrits van Rhee
Haematologica|April 29, 2022
Nearly 70 years later: the continued unraveling of Castleman diseaseFrits Van Rhee
Blood|October 31, 2009
Turning up the heat on myelomaFrits van Rhee
Blood|May 17, 2014
Engineering more efficacious antibody therapy for myelomaFrits van Rhee
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Con: allogeneic transplantation in multiple myelomaFrits van Rhee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune systemFrits van Rhee
Blood Reviews|December 13, 2023
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advancesEvan Lang, Frits van Rhee
Blood|April 20, 2019
Storming the Castle with TCPFrits van Rhee, Katie Stone
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|August 24, 2022
Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal MassFrits van Rhee
Nature Clinical Practice. Oncology|November 7, 2007
Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?Frits van Rhee
Lancet (London, England)|May 18, 2010
Light-chain MGUS: implications for clinical practiceFrits van Rhee
Haematologica|April 29, 2022
Nearly 70 years later: the continued unraveling of Castleman diseaseFrits Van Rhee
Blood|October 31, 2009
Turning up the heat on myelomaFrits van Rhee
Blood|May 17, 2014
Engineering more efficacious antibody therapy for myelomaFrits van Rhee
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Con: allogeneic transplantation in multiple myelomaFrits van Rhee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune systemFrits van Rhee
Blood Reviews|December 13, 2023
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advancesEvan Lang, Frits van Rhee
Blood|April 20, 2019
Storming the Castle with TCPFrits van Rhee, Katie Stone
Pageof 28